Ingelvac PRRSFLEX EU lyophilisate and solvent for suspension for injection for pigs
Ingelvac PRRSFLEX EU lyophilisate and solvent for suspension for injection for pigs
Authorised
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Product identification
Medicine name:
Ingelvac PRRSFLEX EU lyophilisate and solvent for suspension for injection for pigs
Ingelvac PRRSFLEX EU, liofilizat i otapalo za suspenziju za injekciju, za svinje
Active substance:
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live3981070.00tissue culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Available in:
-
Croatia
Package description:
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 25 solvent vials of 250 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 25 solvent vials of 100 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 25 solvent vials of 50 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 25 solvent vials of 10 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 12 solvent vials of 250 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 12 solvent vials of 100 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 12 solvent vials of 50 ml packed in a separate cardboard box.
- Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 12 solvent vials of 10 ml packed in a separate cardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.25 lyophilisate vials of 250 ml (250 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.25 lyophilisate vials of 100 ml (100 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.25 lyophilisate vials of 50 ml (50 doses)packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.25 lyophilisate vials of 10 ml (10 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.12 lyophilisate vials of 250 ml (250 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.12 lyophilisate vials of 100 ml (100 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.12 lyophilisate vials of 50 ml (50 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.12 lyophilisate vials of 10 ml (10 doses) packed in a separatecardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 1 lyophilisate vial of 250 ml (250 doses) and 1 solvent vial of 250 ml packed in one cardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 1 lyophilisate vial of 100 ml (100 doses) and 1 solvent vial of 100 ml packed in one cardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 1 lyophilisate vial of 50 ml (50 doses) and 1 solvent vial of 50ml packed in one cardboard box.
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with bromo- or chlorobutyl rubber stopper and aluminium seal. 1 lyophilisate vial of 10 ml (10 doses) and 1 solvent vial of 10 ml packed in one cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories (Ireland) Limited
- Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/20-01/141
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0443/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 25/03/2022
How useful was this page?: